Trial
NCT03068754
Study of Acthar® Gel (Acthar) for Amyotrophic Lateral Sclerosis (ALS)
Phase IITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Mallinckrodt
Collaborators
—
Condition
Amyotrophic Lateral Sclerosis
Intervention
Acthar
Why stopped
As recommended by the study's independent Data and Safety Monitoring Board (DSMB)
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-10-14